Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosis

Microbes and Infection

Volumn 10, Issue 12-13, 2008, Pages 1393-1397

  Jiang, Shinn Jong ^a   Campbell, Lee Ann ^a   Berry, Mark W ^a   Rosenfeld, Michael E ^a   Kuo, Cho Chou ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Mouse model; Retinoic acid treatment

Indexed keywords

RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL MATURATION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG MECHANISM; FOAM CELL; HYPERLIPIDEMIA; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE MODELS, ANIMAL; FOAM CELLS; HUMANS; HYPERLIPIDEMIAS; LUNG; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA, BACTERIAL; SPECIFIC PATHOGEN-FREE ORGANISMS; TREATMENT OUTCOME; TRETINOIN;

ANIMALIA; CHLAMYDOPHILA PNEUMONIAE; MUS;

EID: 54849439071     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.07.022     Document Type: Article

References (20)

1. Campbell L.A., and Kuo C.-C. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis (reviews). Nat. Rev. Microbiol. 2 (2004) 23-32
2. Kalayoglu M.V., Hoerneman B., LaVerda D., Morrison S.G., Morrison R.P., and Byrne G.I. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J. Infect. Dis. 180 (1999) 780-790
3. Kuo C.-C., Takahashi N., Swanson A.F., Ozeki Y., and Hakomori S.I. An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J. Clin. Investig. 98 (1996) 2813-2818
4. Kuo C.-C., Lee A., and Campbell L.A. Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects attachment and infectivity of the organisms in human epithelial and endothelial cells. Infect. Immun. 72 (2004) 6699-6701
5. Campbell L.A., Lee A., and Kuo C.-C. Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects infectivity in the mouse model of lung infection. Infect. Immun. 74 (2006) 3027-3029
6. Puolakkainen M., Kuo C.-C., and Campbell L.A. Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infect. Immun. 73 (2005) 4620-4625
7. Puolakkainen M., Lee A., Nosaka T., Fukushi H., Kuo C.-C., and Lee L.A. Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors. Microb. Pathog. 44 (2007) 410-416
8. Kuo C.-C., Lee A., Jiang S.-J., Yaraei K., and Campbell L.A. Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy. Microb. Infect. 9 (2007) 1139-1141
9. Kang J.X., Li Y., and Leaf A. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13671-13676
10. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 (1996) 940-954
11. Isaacs C.E., Xu W., Pullarkat R.K., and Kascsak R. Retinoic acid reduces the yield of herpes simplex virus in Vero cells and alters the N-glycosylation of viral envelope proteins. Antivir. Res. 47 (2000) 29-40
12. Blessing E., Campbell L.A., Rosenfeld M.E., Chough N., and Kuo C.-C. Chlamydia pneumoniae infection accelerates hyperlipidaemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158 (2001) 13-17
13. GISSI-Prevenzione Investigators. Dietary supplementation with n - 3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 354 (1999) 447-455
14. The Heart Outcomes Prevention Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med. 342 (2000) 154-160
15. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 23-33
16. Oh G.S., Pae H.O., Seo W.G., Shin M.K., Kim I.K., Chai K.Y., Yun Y.G., Kwon T.O., Lim J.S., and Chung H.T. Inhibitory effect of retinoic acid on expression of inducible nitric oxide synthase gene in L929 cells. Immunopharmacol. Immunotoxicol. 23 (2001) 335-342
17. Brunetti C.R., Burke R.L., Kornfeld S., Gregory W., Masiarz F.R., Dingwell K.S., and Johnson D.C. Herpes simplex virus glycoprotein D acquired mannose 6-phosphate residue and binds to mannose 6-phosphate receptors. J. Biol. Chem. 269 (1994) 17067-17074
18. Chen J.J., Zhu Z., Gershon A.A., and Gershon M.D. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 199 (2004) 915-926
19. Murata T., Suzuki M., Hattori M., Takagi A., Kozima T., Tanizawa T., Asano H., Hotta T., and Saito H. Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line. J. Biol. Chem. 277 (2002) 9936-9943
20. Wolf K., and Hackstadt T. Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells. Cell. Microbiol. 3 (2001) 145-152